MN2.F Mentice AB

Healthcare Medical Devices Frankfurt Exchange
1.35 EUR
Close of Nov 12, 2026
1.11 1.51
Market cap
EUR 38.0M
P/E
-
P/B
3.43x
ROE
-28.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is MN2.F undervalued?

Graham number

The Graham number of Mentice AB cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mentice AB fundamental analysis

No fundamental analysis for Mentice AB yet.

Mentice AB stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mentice AB

Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedural learning models; peripheral vascular; patient simulator accessories and extens…

Full company profile